Matches in Wikidata for { <http://www.wikidata.org/entity/Q87931476> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q87931476 description "clinical trial" @default.
- Q87931476 description "ensayu clínicu" @default.
- Q87931476 description "klinisch onderzoek" @default.
- Q87931476 description "клінічне випробування" @default.
- Q87931476 name "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 name "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 type Item @default.
- Q87931476 label "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 label "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 prefLabel "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 prefLabel "Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults" @default.
- Q87931476 P1132 Q87931476-01B70B72-8D9D-4B3B-A034-52CDE004986D @default.
- Q87931476 P1476 Q87931476-EE61D7C6-1A70-4519-A3C2-07ED4AB936CB @default.
- Q87931476 P17 Q87931476-1C59FF64-EFEC-49EE-B1E0-C142E178F896 @default.
- Q87931476 P2899 Q87931476-AE8458B0-5871-4C0B-86DD-7BA51C4D548E @default.
- Q87931476 P3098 Q87931476-E84D21CB-63C2-4698-82C9-E9C155BA9ADF @default.
- Q87931476 P31 Q87931476-4E45631C-D852-47E2-BCD2-4F2895D4EA31 @default.
- Q87931476 P4844 Q87931476-6A9A314D-6F57-4510-B6D6-D64E936F4C6A @default.
- Q87931476 P4844 Q87931476-AD62C5D5-057B-4493-A08D-D1152BF2BE26 @default.
- Q87931476 P4844 Q87931476-EA56C111-7410-4683-B374-09003996DBC5 @default.
- Q87931476 P580 Q87931476-0237DAB6-2F8E-4436-916E-A6D1328AE977 @default.
- Q87931476 P582 Q87931476-4C41E060-480E-4233-BB28-BEC0B523572A @default.
- Q87931476 P6099 Q87931476-460477FA-E9D2-443D-A748-1757B08E3798 @default.
- Q87931476 P8363 Q87931476-B5B8A53B-137E-4FFF-8E70-0271731DC149 @default.
- Q87931476 P921 Q87931476-9C5C3B65-A848-4955-B9F8-E2ADDEB6AC0A @default.
- Q87931476 P1132 "+386" @default.
- Q87931476 P1476 "A Randomized Non-Inferiority Trial to Compare the Efficacy of Switching From Protease-Inhibitor Based Second-Line Therapy to Bictegravir-Tenofovir Alafenamide-Emtricitabine in Virologically Suppressed Adults in Haiti" @default.
- Q87931476 P17 Q790 @default.
- Q87931476 P2899 "+18" @default.
- Q87931476 P3098 "NCT04311957" @default.
- Q87931476 P31 Q30612 @default.
- Q87931476 P4844 Q155954 @default.
- Q87931476 P4844 Q422604 @default.
- Q87931476 P4844 Q50315992 @default.
- Q87931476 P580 "2020-06-01T00:00:00Z" @default.
- Q87931476 P582 "2022-05-31T00:00:00Z" @default.
- Q87931476 P6099 Q42825046 @default.
- Q87931476 P8363 Q78089383 @default.
- Q87931476 P921 Q15787 @default.